FIIs stake in IPCA Laboratories crosses 24%

19 Oct 2013 Evaluate

Foreign institutional investors (FIIs) have increased their stake in IPCA Laboratories and their purchase has reached the trigger limit of 24%.

The Reserve Bank of India (RBI) notified that FIIs has crossed the overall limit of 24% of paid-up capital of the company. Therefore, no further purchases of shares of this company would be allowed through stock exchanges in India on behalf of FIIs.

IPCA Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×